For several years, deaths caused by cancer were increasing exponentially. All big seminars arranged to counter this fatal disease were concentrated on finding the best cures and treatments to bring the fatality rate to a stable ratio and then an eventual decline was targeted, one step at a time.
Recently, if we talk about nearer decades, deaths caused by cancer are on a decline. This has raised another major query for researchers and doctors as to whether or not some patients receive excess treatment for their cancer?
Sadly, the answer to this question presented just two days ago in a meeting held in Chicago by the American Society of Clinical Oncology is affirmative. Yes, some patients are getting too much treatment to cure their cancer. One eye-opening instance that was highlighted as the most major concern, talks about the most common type of breast cancer called the hormone-positive, HER-2 negative condition.
For a majority of female patients who are suffering from this, where cancer has not entered into their lymph nodes, there is a good news. The latest research has revealed that an anti-hormone treatment after the breast removal surgery is more than adequate to tackle a future threat if any. None of these ladies will benefit from cycles of painful and chemically toxic chemotherapy.
This reveals that treatment for this most common form of breast cancer will become easier for a large population of women suffering from it. Additionally, for all those recovering patients who took the decision to not go through rounds of chemotherapy, they can be reassured that they have made the right decision.
Another research presented at this meeting revealed that patients who are victims of an advanced form of kidney cancer can also avoid the option of getting the surgery done. Dr. Bruce Johnson, who is the president of ASCO shed light on this finding. He revealed that a clinical study done on over 450 patients in Paris, France presented the result that surgery for this form of cancer has no advantage at all.
Individuals who went ahead with kidney removal surgery did not do better than those who went through cycles of chemotherapy and said no to surgery. Rather those who opted out of surgery, not only saved the costs of surgical procedure but were spared from the painful ordeal as well.
If researched upon further, many other cancer treatments and cures might be revealed that are virtually not required to begin with or are maybe even harmful. If we articulate, we realize that the most experienced medical consultants follow the long-time practices that are following little to no evidence and mostly rely on old traditions and methods.
But what worries the ASCO, is that the government is slowly losing interest in such a type of research which is not only lengthy but requires heavy amounts of funding as well. This is a direct threat to the survival of such programs that even though take a few decades to reach upon solid results and findings, but what they deliver is revolutionary and may help patients of various diseases in dealing with their conditions in a less painful way.